SureSeq Myeloid MRD Plus NGS Panel
Acute Myeloid Leukemia (MRD detection)
CommercialActive
Key Facts
Indication
Acute Myeloid Leukemia (MRD detection)
Phase
Commercial
Status
Active
Company
About Oxford Gene Technology
Oxford Gene Technology (OGT) is a leading global diagnostic genomics company founded in 1995, offering a portfolio of FISH, NGS, and array products for clinical and research use in oncology and rare diseases. The company operates on a partnership model, providing assay development and companion diagnostic services, particularly for haematological malignancies. With products used in over 85 countries and a strong emphasis on customer collaboration, OGT is positioned as a key enabler of precision medicine, leveraging its deep experience in molecular genetics to deliver reliable genomic insights.
View full company profile